| scholarly article | Q13442814 |
| P356 | DOI | 10.1093/AJCN/73.2.361S |
| P698 | PubMed publication ID | 11157342 |
| P2093 | author name string | Schrezenmeir J | |
| de Vrese M | |||
| P433 | issue | 2 Suppl | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | probiotics | Q1816730 |
| P304 | page(s) | 361S-364S | |
| P577 | publication date | 2001-02-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | American Journal of Clinical Nutrition | Q7713500 |
| P1476 | title | Probiotics, prebiotics, and synbiotics--approaching a definition | |
| P478 | volume | 73 |
| Q33458837 | A pilot study on the effect of a symbiotic mixture in irritable bowel syndrome: an open-label, partially controlled, 6-month extension of a previously published trial |
| Q33455506 | A randomised clinical trial (RCT) of a symbiotic mixture in patients with irritable bowel syndrome (IBS): effects on symptoms, colonic transit and quality of life |
| Q38162148 | A review of the advancements in probiotic delivery: Conventional vs. non-conventional formulations for intestinal flora supplementation |
| Q90090317 | A synbiotic concept containing spore-forming Bacillus strains and a prebiotic fiber blend consistently enhanced metabolic activity by modulation of the gut microbiome in vitro |
| Q64064286 | A theoretical framework for controlling complex microbial communities |
| Q26776089 | An Introduction to the Avian Gut Microbiota and the Effects of Yeast-Based Prebiotic-Type Compounds as Potential Feed Additives |
| Q36585052 | An oral preparation of Lactobacillus acidophilus for the treatment of uncomplicated acute watery diarrhoea in Vietnamese children: study protocol for a multicentre, randomised, placebo-controlled trial |
| Q51732186 | Anti-adhesion Property of the Potential Probiotic Strain Lactobacillus fermentum 8711 Against Methicillin-Resistant Staphylococcus aureus (MRSA). |
| Q42254382 | Antiviral activity of GuiQi polysaccharides against enterovirus 71 in vitro |
| Q28066050 | Applications of In Ovo Technique for the Optimal Development of the Gastrointestinal Tract and the Potential Influence on the Establishment of Its Microbiome in Poultry |
| Q37156788 | Autochthonous Bacterial Isolates Successfully Stimulate In vitro Peripheral Blood Leukocytes of the European Sea Bass (Dicentrarchus labrax) |
| Q35327040 | Bacteria isolated from bats inhibit the growth of Pseudogymnoascus destructans, the causative agent of white-nose syndrome |
| Q34406197 | Barley β-glucans-containing food enhances probiotic performances of beneficial bacteria |
| Q37351569 | Beneficial health effects of milk and fermented dairy products--review |
| Q26748468 | Biochemical Engineering Approaches for Increasing Viability and Functionality of Probiotic Bacteria |
| Q58769723 | Broad Bean ( L.) Induces Intestinal Inflammation in Grass Carp ( C. et V) by Increasing Relative Abundances of Intestinal Gram-Negative and Flagellated Bacteria |
| Q37099286 | Characterization of two novel alpha-glucosidases from Bifidobacterium breve UCC2003. |
| Q39265428 | Clinical Evidence for the Microbiome in Inflammatory Diseases |
| Q91948457 | Clinical effect of probiotics in prevention or treatment of gastrointestinal disease in dogs: A systematic review |
| Q58710211 | Cnidarian Interaction with Microbial Communities: From Aid to Animal's Health to Rejection Responses |
| Q36087381 | Colonic flora, Probiotics, Obesity and Diabetes |
| Q42424691 | Controlling the Microbiome: Microhabitat Adjustments for Successful Biocontrol Strategies in Soil and Human Gut. |
| Q64096846 | Dietary Components That May Influence the Disturbed Gut Microbiota in Chronic Kidney Disease |
| Q42267314 | Differential effect on cell-mediated immunity in human volunteers after intake of different lactobacilli |
| Q35826608 | Diversity of key players in the microbial ecosystems of the human body |
| Q33423038 | Does the use of probiotics/synbiotics prevent postoperative infections in patients undergoing abdominal surgery? A meta-analysis of randomized controlled trials |
| Q90150395 | Effect of Auricularia auricula aqueous extract on survival of Lactobacillus acidophilus La-5 and Bifidobacterium bifidum Bb-12 and on sensorial and functional properties of synbiotic yogurt |
| Q55093174 | Effect of Honey on Diarrhea and Fecal Microbiotain in Critically Ill Tube-Fed Patients: A Single Center Randomized Controlled Study. |
| Q82970230 | Effect of synbiotic therapy on the incidence of ventilator associated pneumonia in critically ill patients: a randomised, double-blind, placebo-controlled trial |
| Q44413902 | Effect of the Probiotic Enterococcus faecium SF68 on Presence of Diarrhea in Cats and Dogs Housed in an Animal Shelter |
| Q60925810 | Effects of Prebiotic and Synbiotic Supplementation on Glycaemia and Lipid Profile in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials |
| Q34681064 | Effects of a Diet-Based Weight-Reducing Program with Probiotic Supplementation on Satiety Efficiency, Eating Behaviour Traits, and Psychosocial Behaviours in Obese Individuals |
| Q36694958 | Effects of gut microbes on nutrient absorption and energy regulation |
| Q91756288 | Effects of preoperative oral administration of glucose solution combined with postoperative probiotics on inflammation and intestinal barrier function in patients after colorectal cancer surgery |
| Q94672912 | Empirically derived dietary patterns and obesity among Iranian Adults: Yazd Health Study-TAMYZ and Shahedieh cohort study |
| Q33463875 | Evaluating the efficacy of probiotic on treatment in patients with small intestinal bacterial overgrowth (SIBO)--a pilot study |
| Q39364975 | Evaluation of plant and fungal extracts for their potential antigingivitis and anticaries activity |
| Q39370710 | Expert consensus document: The International Scientific Association for Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of prebiotics. |
| Q36014797 | Fermented Milk Consumption and Common Infections in Children Attending Day-Care Centers: A Randomized Trial |
| Q35671137 | Folate Production by Probiotic Bacteria |
| Q34458414 | From stool transplants to next-generation microbiota therapeutics |
| Q24612050 | From structure to function: the ecology of host-associated microbial communities |
| Q33622636 | Functional foods and their role in cancer prevention and health promotion: a comprehensive review |
| Q22241118 | Gut Microbiota and Its Possible Relationship With Obesity |
| Q34609555 | Gut microbiota and hepatic encephalopathy |
| Q99731217 | Gut microbiota and old age: Modulating factors and interventions for healthy longevity |
| Q47117314 | Gut microbiota as a potential target of metabolic syndrome: the role of probiotics and prebiotics |
| Q47236027 | Gut microbiota in the pathogenesis of inflammatory bowel disease |
| Q37585321 | Handling stress may confound murine gut microbiota studies |
| Q92987843 | Health Professionals' Knowledge of Probiotics: An International Survey |
| Q42122595 | Highly hydrolytic reuteransucrase from probiotic Lactobacillus reuteri strain ATCC 55730. |
| Q26779114 | Human Microbiome Engineering: The Future and Beyond |
| Q37542275 | Identification of Lactobacillus plantarum, Lactobacillus pentosus and Lactobacillus fermentum from honey stomach of honeybee |
| Q34667531 | Identification of N-acetylhexosamine 1-kinase in the complete lacto-N-biose I/galacto-N-biose metabolic pathway in Bifidobacterium longum |
| Q37628338 | Impact of Probiotic Administration on Serum C-Reactive Protein Concentrations: Systematic Review and Meta-Analysis of Randomized Control Trials |
| Q28821853 | In vitro and in vivo evaluation of the prebiotic effect of raw and roasted almonds (Prunus amygdalus) |
| Q57111381 | In vitro and in vivo evidences for innate immune stimulators lactic acid bacterial starters isolated from fermented camel dairy products |
| Q33437877 | Influence of E. coli strain Nissle 1917 (EcN) on intestinal gas dynamics and abdominal sensation |
| Q38548567 | Innate immunity and inflammatory bowel disease: a review of clinical evidence and future application |
| Q39764229 | Integrative effects of feeding Aspergillus awamori and fructooligosaccharide on growth performance and digestibility in broilers: promotion muscle protein metabolism. |
| Q41424894 | Interactions between Intestinal Microbiota and Host Immune Response in Inflammatory Bowel Disease |
| Q33626582 | Intestinal alkaline phosphatase promotes gut bacterial growth by reducing the concentration of luminal nucleotide triphosphates |
| Q92032230 | Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives |
| Q35062098 | Intestinal microflora as a therapeutic target in inflammatory bowel disease |
| Q36890446 | Investigational new drugs in the treatment of inflammatory bowel disease: a review |
| Q44959202 | Lactobacilli and enterococci--potential probiotics for dogs |
| Q39606107 | Lactobacilli reduce cell cytotoxicity caused by Streptococcus pyogenes by producing lactic acid that degrades the toxic component lipoteichoic acid. |
| Q34013041 | Lactobacilli, bifidobacteria and E. coli nissle induce pro- and anti-inflammatory cytokines in peripheral blood mononuclear cells |
| Q83704795 | Lactobacillus plantarum 299v Does Not Reduce Enteric Bacteria or Bacterial Translocation in Patients Undergoing Colon Resection |
| Q36692184 | Lactobacillus plantarum LG42 isolated from gajami sik-hae inhibits adipogenesis in 3T3-L1 adipocyte |
| Q49833714 | Lactobacillus rhamnosus reduces parasite load on Toxocara canis experimental infection in mice, but has no effect on the parasite in vitro |
| Q41923219 | Lipoteichoic Acid of Probiotic Lactobacillus plantarum Attenuates Poly I:C-Induced IL-8 Production in Porcine Intestinal Epithelial Cells |
| Q36230553 | Long-Term Transcriptomic Effects of Prebiotics and Synbiotics Delivered In Ovo in Broiler Chickens |
| Q35771490 | Maintenance of remission in Crohn's disease: current and emerging therapeutic options |
| Q34133520 | Measuring kinetic dissociation/association constants between Lactococcus lactis bacteria and mucins using living cell probes |
| Q99565507 | Mechanisms and microbial influences on CTLA-4 and PD-1-based immunotherapy in the treatment of cancer: a narrative review |
| Q94400767 | Medical interventions for prevention and treatment of hepatic encephalopathy in adults with cirrhosis: a network meta‐analysis |
| Q35914935 | Metabolomic applications to decipher gut microbial metabolic influence in health and disease |
| Q44428084 | Microbial Therapeutics Designed for Infant Health. |
| Q26750985 | Modulating Composition and Metabolic Activity of the Gut Microbiota in IBD Patients |
| Q36449677 | Modulation of PPAR-γby Nutraceutics as Complementary Treatment for Obesity-Related Disorders and Inflammatory Diseases |
| Q38045310 | Necrotizing Enterocolitis in Very Low Birth Weight Infants: A Systemic Review |
| Q34104407 | New Concepts of Microbial Translocation in the Neonatal Intestine: Mechanisms and Prevention |
| Q30991282 | Novel putative galactose operon involving lacto-N-biose phosphorylase in Bifidobacterium longum |
| Q61847159 | Nutritional modulation of the intestinal microbiota; future opportunities for the prevention and treatment of neuroimmune and neuroinflammatory disease |
| Q33563887 | Pediatric non-alcoholic fatty liver disease: New insights and future directions |
| Q41438891 | Performance, biochemical and haematological responses, and relative organ weights of laying hens fed diets supplemented with prebiotic, probiotic and synbiotic. |
| Q55040688 | Pharmacomicrobiomics: exploiting the drug-microbiota interactions in anticancer therapies. |
| Q55261184 | Phytochemicals That Influence Gut Microbiota as Prophylactics and for the Treatment of Obesity and Inflammatory Diseases. |
| Q37285115 | Prebiotics in chronic intestinal inflammation |
| Q37351541 | Prebiotics, probiotics, synbiotics in surgery--are they only trendy, truly effective or even dangerous? |
| Q37051855 | Preparation, characterization and in vitro antioxidative potential of synbiotic fermented dairy products. |
| Q26827300 | Prevention of ventilator-associated pneumonia |
| Q54466980 | Preventive effects of the probiotic Escherichia coli strain Nissle 1917 on acute secretory diarrhea in a pig model of intestinal infection. |
| Q47751932 | Probiotic Incorporation in Edible Films and Coatings: Bioactive Solution for Functional Foods |
| Q58236981 | Probiotic Lactobacillus strains: in vitro and in vivo studies |
| Q45091618 | Probiotic antigens stimulate hepatic natural killer T cells |
| Q45540910 | Probiotic bacteria stimulate virus-specific neutralizing antibodies following a booster polio vaccination |
| Q24185844 | Probiotic fermented milk or isolated probiotic bacteria for primary prevention of cardiovascular disease in adults |
| Q24200391 | Probiotic fermented milk or isolated probiotic bacteria for primary prevention of cardiovascular disease in adults |
| Q33847243 | Probiotic sonicates selectively induce mucosal immune cells apoptosis through ceramide generation via neutral sphingomyelinase |
| Q47114796 | Probiotic, Prebiotic, and Brain Development. |
| Q91986606 | Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a randomised controlled trial |
| Q35991591 | Probiotics [LGG-BB12 or RC14-GR1] versus placebo as prophylaxis for urinary tract infection in persons with spinal cord injury [ProSCIUTTU]: a study protocol for a randomised controlled trial |
| Q34627560 | Probiotics affect virulence-related gene expression in Escherichia coli O157:H7 |
| Q74404043 | Probiotics and Functional Foods in Gastrointestinal Disorders |
| Q37708418 | Probiotics and Nonalcoholic Fatty liver Disease |
| Q44556522 | Probiotics and Prebiotics for the Prevention of Necrotizing Enterocolitis |
| Q50202853 | Probiotics and Synbiotics Decrease Postoperative Sepsis in Elective Gastrointestinal Surgical Patients: a Meta-Analysis |
| Q34317609 | Probiotics and functional foods in gastrointestinal disorders |
| Q83929578 | Probiotics and inflammatory bowel diseases |
| Q24236083 | Probiotics for hepatic encephalopathy |
| Q24235259 | Probiotics for patients with hepatic encephalopathy |
| Q38946102 | Probiotics for people with hepatic encephalopathy |
| Q24198998 | Probiotics for preventing urinary tract infection in people with neuropathic bladder |
| Q40061031 | Probiotics for preventing urinary tract infection in people with neuropathic bladder. |
| Q24186954 | Probiotics for preventing urinary tract infections in adults and children |
| Q24235033 | Probiotics for preventing urinary tract infections in adults and children |
| Q24193079 | Probiotics for preventing ventilator-associated pneumonia |
| Q24235329 | Probiotics for preventing ventilator-associated pneumonia |
| Q24246901 | Probiotics for the maintenance of remission in Crohn's disease |
| Q24186991 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
| Q24235039 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
| Q24245196 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
| Q91644124 | Probiotics for the prevention of pediatric antibiotic-associated diarrhea |
| Q42156879 | Probiotics improve survival of septic rats by suppressing conditioned pathogens in ascites |
| Q56517232 | Probiotics, prebiotics and synbiotics for chronic kidney disease: protocol for a systematic review and meta-analysis |
| Q35118075 | Probiotics: Considerations for Human Health |
| Q64258191 | Probiotics: How Effective Are They in the Fight against Obesity? |
| Q38701813 | Probiotics: Potent Immunomodulatory Tool Against Allergy |
| Q37488165 | Role of gut microbiota in liver diseases |
| Q36550274 | Role of nutraceuticals in human health |
| Q39077604 | Starter formula enriched in prebiotics and probiotics ensures normal growth of infants and promotes gut health: a randomized clinical trial. |
| Q33912533 | Survival and synergistic growth of mixed cultures of bifidobacteria and lactobacilli combined with prebiotic oligosaccharides in a gastrointestinal tract simulator |
| Q34852895 | Synbiotic containing Bacillus coagulans and fructo-oligosaccharides for functional abdominal pain in children |
| Q36180296 | Synbiotic enhances immune responses against infectious bronchitis, infectious bursal disease, Newcastle disease and avian influenza in broiler chickens |
| Q35801971 | Synbiotic potential of Doogh supplemented with free and encapsulated Lactobacillus plantarum LS5 and Helianthus tuberosus inulin |
| Q36429116 | Synbiotics and gastrointestinal function-related quality of life after elective colorectal cancer resection |
| Q28818193 | Synbiotics for Broiler Chickens-In Vitro Design and Evaluation of the Influence on Host and Selected Microbiota Populations following In Ovo Delivery |
| Q24188236 | Systemic nutritional interventions for treating foot ulcers in people with diabetes |
| Q35667803 | Th1 Cytokine Production Induced by Lactobacillus acidophilus in BALB/c Mice Bearing Transplanted Breast Tumor. |
| Q35773864 | The Effect of Bacillus-based Feed Additive on Growth Performance, Nutrient Digestibility, Fecal Gas Emission, and Pen Cleanup Characteristics of Growing-finishing Pigs |
| Q26751265 | The Gut Microbiota and Immune System Relationship in Human Graft-versus-Host Disease |
| Q60924600 | The Prebiotic Activity of Simulated Gastric and Intestinal Digesta of Polysaccharides from the |
| Q91576362 | The effect of synbiotics supplementation on anthropometric indicators and lipid profiles in women with polycystic ovary syndrome: a randomized controlled trial |
| Q49386702 | The effects of sodium butyrate and inulin supplementation on angiotensin signaling pathway via promotion of Akkermansia muciniphila abundance in type 2 diabetes; A randomized, double-blind, placebo-controlled trial |
| Q35942511 | The gut microbiota and irritable bowel syndrome: friend or foe? |
| Q64949447 | The relationship between the structural characteristics of lactobacilli-EPS and its ability to induce apoptosis in colon cancer cells in vitro. |
| Q55397269 | The role of probiotics, prebiotics and synbiotics in animal nutrition. |
| Q80701381 | Therapeutic effect of Lactobacillus acidophilus-SDC 2012, 2013 in patients with irritable bowel syndrome |
| Q27028844 | Therapeutic options in pediatric non alcoholic fatty liver disease: current status and future directions |
| Q37360378 | Timely approaches to identify probiotic species of the genus Lactobacillus |
| Q36837773 | Top-down systems biology integration of conditional prebiotic modulated transgenomic interactions in a humanized microbiome mouse model |
| Q35590684 | Towards a more comprehensive concept for prebiotics |
| Q36068446 | Trends in dairy and non-dairy probiotic products - a review |
| Q92992517 | Unique genetic basis of the distinct antibiotic potency of high acetic acid production in the probiotic yeast Saccharomyces cerevisiae var. boulardii |
| Q35140083 | Use of mouse models to evaluate the persistence, safety, and immune modulation capacities of lactic acid bacteria |
| Q36900173 | Use of probiotics in aquaculture. |
| Q84349323 | [Outside-in. Probiotic topical agents] |
Search more.